These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 1765105)
1. Effect of the amine non-leaving group on the structure and stability of DNA complexes with cis-[Pt(R-NH2)2(NO3)2]. Butour JL; Alvinerie P; Souchard JP; Colson P; Houssier C; Johnson NP Eur J Biochem; 1991 Dec; 202(3):975-80. PubMed ID: 1765105 [TBL] [Abstract][Full Text] [Related]
2. Improving of Anticancer Activity and Solubility of Cisplatin by Methylglycine and Methyl Amine Ligands Against Human Breast Adenocarcinoma Cell Line. Shams Abyaneh FS; Eslami Moghadam M; Divsalar A; Ajloo D; Hosaini Sadr M Appl Biochem Biotechnol; 2018 Oct; 186(2):271-291. PubMed ID: 29516403 [TBL] [Abstract][Full Text] [Related]
3. Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro. Kostrhunova H; Vrana O; Suchankova T; Gibson D; Kasparkova J; Brabec V Chem Res Toxicol; 2010 Nov; 23(11):1833-42. PubMed ID: 20939593 [TBL] [Abstract][Full Text] [Related]
4. The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG). Lempers EL; Bloemink MJ; Brouwer J; Kidani Y; Reedijk J J Inorg Biochem; 1990 Sep; 40(1):23-35. PubMed ID: 2283508 [TBL] [Abstract][Full Text] [Related]
6. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines. Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637 [TBL] [Abstract][Full Text] [Related]
7. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts. Kasparkova J; Novakova O; Farrell N; Brabec V Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers. Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964 [TBL] [Abstract][Full Text] [Related]
9. Ring-substituted diaqua(1,2-diphenylethylenediamine)platinum(II) sulfate reacts with DNA through a dissociable complex. Bernges F; Holler E Eur J Biochem; 1992 Sep; 208(3):573-9. PubMed ID: 1396663 [TBL] [Abstract][Full Text] [Related]
10. Effect of lipophilicity of amylamine and amylglycine ligands on biological activity of new anticancer cisplatin analog. Safa Shams Abyaneh F; Eslami Moghadam M; Hossaini Sadr M; Divsalar A J Biomol Struct Dyn; 2018 Mar; 36(4):893-905. PubMed ID: 28335682 [TBL] [Abstract][Full Text] [Related]
11. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships. Navarro JA; Salas JM; Romero MA; Vilaplana R; Gonzalez-Vílchez F; Faure R J Med Chem; 1998 Jan; 41(3):332-8. PubMed ID: 9464364 [TBL] [Abstract][Full Text] [Related]
12. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair. Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015 [TBL] [Abstract][Full Text] [Related]
14. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand. Frybortova M; Novakova O; Stepankova J; Novohradsky V; Gibson D; Kasparkova J; Brabec V J Inorg Biochem; 2013 Sep; 126():46-54. PubMed ID: 23770803 [TBL] [Abstract][Full Text] [Related]
15. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids. Lippert B Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842 [TBL] [Abstract][Full Text] [Related]
16. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent. Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents. Hollis LS; Sundquist WI; Burstyn JN; Heiger-Bernays WJ; Bellon SF; Ahmed KJ; Amundsen AR; Stern EW; Lippard SJ Cancer Res; 1991 Apr; 51(7):1866-75. PubMed ID: 2004370 [TBL] [Abstract][Full Text] [Related]
18. DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2]. Brabec V; Vrána O; Nováková O; Kleinwächter V; Intini FP; Coluccia M; Natile G Nucleic Acids Res; 1996 Jan; 24(2):336-41. PubMed ID: 8628659 [TBL] [Abstract][Full Text] [Related]
19. Multiple Condensation Reactions Involving Pt(II) /Pd(II) -OH2 , Pt-NH3 , and Cytosine-NH2 Groups: New Twists in Cisplatin-Nucleobase Chemistry. Yin-Bandur L; Sanz Miguel PJ; Rodríguez-Santiago L; Sodupe M; Berghaus M; Lippert B Chemistry; 2016 Sep; 22(38):13653-68. PubMed ID: 27516223 [TBL] [Abstract][Full Text] [Related]
20. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O. Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]